You are here

Article info

Article menu
Heart failure and cardiomyopathies
Original article
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

Authors

  1. Correspondence to Dawn Lee, BresMed, North Church House, 84 Queen St, Sheffield S1 2DW, UK; dlee{at}bresmed.co.uk
View Full Text

Citation

Lee D, Wilson K, Akehurst R for the Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) Study, et al
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
Heart 2014;100:1681-1687.

Publication history

  • Received February 14, 2014
  • Revised June 1, 2014
  • Accepted June 3, 2014
  • First published July 3, 2014.
Online issue publication 
October 25, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/